Targeting the HIV trans-activation responsive region--approaches towards RNA-binding drugs

Chembiochem. 2003 Oct 6;4(10):972-8. doi: 10.1002/cbic.200300652.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acridines / pharmacology
  • Aminoglycosides / chemistry
  • Aminoglycosides / pharmacology
  • Benzimidazoles / pharmacology
  • Binding Sites
  • Drug Delivery Systems / trends*
  • Drug Design
  • Gene Products, tat / chemistry
  • Gene Products, tat / drug effects*
  • Gene Products, tat / genetics
  • HIV Long Terminal Repeat / drug effects*
  • HIV Long Terminal Repeat / genetics
  • HeLa Cells / drug effects
  • HeLa Cells / metabolism
  • Humans
  • Ligands
  • Models, Molecular
  • Peptides / chemistry
  • Peptides / pharmacology
  • Quinoxalines / pharmacology
  • RNA / chemistry
  • RNA / metabolism
  • Technology, Pharmaceutical / trends*

Substances

  • Acridines
  • Aminoglycosides
  • Benzimidazoles
  • CPG 40336A
  • Gene Products, tat
  • Ligands
  • Peptides
  • Quinoxalines
  • hoechst 32258
  • RNA